false 0001635077 0001635077 2025-01-03 2025-01-03 0001635077 ACON:CommonStockParValue0.00001PerShareMember 2025-01-03 2025-01-03 0001635077 ACON:WarrantsEachExercisableForOneShareOfCommonStockMember 2025-01-03 2025-01-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 3, 2025 (January 3, 2025)

 

 

 

Aclarion, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware 001-41358 47-3324725
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

 

8181 Arista Place, Suite 100  
Broomfield, Colorado 80021
(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (833) 275-2266

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

  Trading  
Title of each class Symbol(s) Name of each exchange on which registered
Common Stock ACON Nasdaq Stock Market
Common Stock Warrants ACONW Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

   

 

 

Item 1.02 Termination of a Material Definitive Agreement.

 

On January 3, 2025, Aclarion, Inc. (the “Company”) gave notice to terminate the At-The-Market Issuance Sales Agreement that the Company entered into with Ascendiant Capital Markets, LLC on September 24, 2024 (the “Sales Agreement”), effective immediately. Under the Sales Agreement, the Company was permitted to sell, from time to time, shares of its common stock, par value $0.00001 per share (the “Common Stock”), having an aggregate offering price of up to $10 million, through an “at the market offering” as defined in Rule 415 under the Securities Act of 1933, as amended. As a result, the “at the market” offering facility under the Sales Agreement is no longer available for use. During the term of the Sales Agreement, the Company had sold 1,606,211 shares of its Common Stock thereunder for aggregate gross proceeds of approximately $0.3 million.

 

A copy of the Sales Agreement was filed as Exhibit 1.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 24, 2024 (the “Prior Form 8-K”). The description of the Sales Agreement contained in this Current Report on Form 8-K does not purport to be complete and is qualified in its entirety by reference to the copy of the Sales Agreement filed as Exhibit 1.1 to the Prior Form 8-K.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 2 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ACLARION, INC.
     
January 3, 2025 By:/s/ John Lorbiecki
  Name: John Lorbiecki
  Title: Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 3 

v3.24.4
Cover
Jan. 03, 2025
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 03, 2025
Entity File Number 001-41358
Entity Registrant Name Aclarion, Inc.
Entity Central Index Key 0001635077
Entity Tax Identification Number 47-3324725
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 8181 Arista Place
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Broomfield
Entity Address, State or Province CO
Entity Address, Postal Zip Code 80021
City Area Code (833)
Local Phone Number 275-2266
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock Par Value 0. 00001 Per Share [Member]  
Title of 12(b) Security Common Stock
Trading Symbol ACON
Security Exchange Name NASDAQ
Warrants Each Exercisable For One Share Of Common Stock [Member]  
Title of 12(b) Security Common Stock Warrants
Trading Symbol ACONW
Security Exchange Name NASDAQ
Aclarion (NASDAQ:ACONW)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Aclarion Charts.
Aclarion (NASDAQ:ACONW)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Aclarion Charts.